LimaCorporate

Healthcare Professionals Access

The following information are exclusively dedicated to Healthcare Professionals. Please click on the confirmation button below if you declare to be a Healthcare Professional.

09 Jun_2025

ARVIS® CE Mark and First Surgery Outside the US

We’re very pleased to share two major milestones for ARVIS®, our proprietary wearable, self-contained augmented reality (AR) surgical guidance platform. 

On May 21st, Dr. Justin Roe of Mater Hospital North Sydney, Australia, successfully performed the first procedure using the ARVIS® Augmented Reality System in combination with the BalanSys Knee System. 

After the procedure, Dr. Roe commented: 
“Using ARVIS® for the first time was a great experience. Being able to bring the data back into the surgical field added to my clinical decision-making. I look forward to seeing the technology evolve to offer more intraoperative information to further the orthopaedic field.” 

Just a few days later, towards the end of May, ARVIS® also received the CE Mark in accordance with EU MDR 2017/745 for both hip and knee applications
The CE mark for the shoulder is expected soon. 

To celebrate, we hosted our first International ARVIS® SkillsLABs in Verona, where leading knee surgeons shared insights, tested applications, and helped to shape the future of AR-guided surgery.  

This achievement marks a significant step in making smart, wearable AR surgical guidance more accessible across Europe, and we’re excited for what’s ahead
Subscribe to our newsletter and follow us on LinkedIn to stay up to date with the latest news. 

Other News

23 Jun_2025

First Surgery Completed with Enovis’ New ArTT System​

18 Jun_2025

Global Recognition for Packaging Innovation: Bettlach Team Honored with…

23 May_2025

Advancing Shoulder Care in Asia: remarkable Prima System SkillsLab Held in…

14 May_2025

PRIMA TT Glenoid Hits 1,000!​

15 Apr_2025

Creating Better Together – One Drop at a Time

07 Apr_2025

Exploring the Future of Hip and Knee Surgery: Highlights from the 2025…